---
figid: PMC3418714__zh89991294640003
figtitle: Kinase inhibitors in CLL
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC3418714
filename: zh89991294640003.jpg
figlink: /pmc/articles/PMC3418714/figure/F3/
number: F3
caption: Kinase inhibitors in CLL. (A) Chemical structures of signal kinase inhibitors.
  (B) Kinase inhibitors and the BCR pathway.
papertitle: The B-cell receptor signaling pathway as a therapeutic target in CLL.
reftext: Jennifer A. Woyach, et al. Blood. 2012 Aug 9;120(6):1175-1184.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7975422
figid_alias: PMC3418714__F3
figtype: Figure
redirect_from: /figures/PMC3418714__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3418714__zh89991294640003.html
  '@type': Dataset
  description: Kinase inhibitors in CLL. (A) Chemical structures of signal kinase
    inhibitors. (B) Kinase inhibitors and the BCR pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCR
  - RN7SL263P
  - PLCG1
  - PLCG2
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - BTK
  - LYN
  - SYK
  - BLNK
  - bcr
  - btk
  - lyn
  - si:ch73-206d17.1
  - syk
  - blnk
  - Fostamatinib
  - Ibrutinib
---
